Our results show that miR-134 significantly inhibits HCC cell invasion and metastasis in vitro and in vivo and further highlights the critical role of ITGB1 and its downstream pathway in miR-134-mediated inhibition of metastasis in HCC. The gene discussed is ITGB1; the disease is hepatocellular carcinoma.